诊断学理论与实践 ›› 2021, Vol. 20 ›› Issue (02): 125-129.doi: 10.16150/j.1671-2870.2021.02.002
杨聚荣, 林利容
收稿日期:
2021-03-20
出版日期:
2021-04-25
发布日期:
2022-06-28
基金资助:
Received:
2021-03-20
Online:
2021-04-25
Published:
2022-06-28
中图分类号:
杨聚荣, 林利容. 慢性肾脏病患者妊娠的管理现状及策略[J]. 诊断学理论与实践, 2021, 20(02): 125-129.
[1] |
Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822.
doi: 10.1016/S0140-6736(12)60033-6 URL |
[2] |
Piccoli GB, Zakharova E, Attini R, et al. Pregnancy in chronic kidney disease: need for higher awareness. A pragmatic review focused on what could be improved in the different CKD stages and phases[J]. J Clin Med, 2018, 7(11):415.
doi: 10.3390/jcm7110415 URL |
[3] |
Shahir AK, Briggs N, Katsoulis J, et al. An observational outcomes study from 1966-2008, examining pregnancy and neonatal outcomes from dialysed women using data from the ANZDATA Registry[J]. Nephrology (Carlton), 2013, 18(4):276-84.
doi: 10.1111/nep.12044 URL |
[4] |
Piccoli G, Bontempo S, Mezza E, et al. Sudden development of low tolerance of dialysis in a young female patient[J]. Nephrol Dial Transplant, 2004, 19(1):255-257.
doi: 10.1093/ndt/gfg517 URL |
[5] |
Cabiddu G, Castellino S, Gernone G, et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy[J]. J Nephrol, 2016, 29(3)277-303.
doi: 10.1007/s40620-016-0285-6 URL |
[6] | 南京总医院, 国家肾脏疾病临床医学研究中心. 慢性肾脏病患者妊娠管理指南[J]. 中华医学杂志, 2017, 97(46):3604-3612. |
[7] | Masafumi F, Keitaro Y, Fumihiko K, et al. Clinical practice guideline for the management of chronic kidney disea-se-mineral and bone disorder[J/OL].(2012-05-23). https://cdn.jsn.or.jp/data/jsn-pregnancy.pdf. |
[8] |
de Castro I, Easterling TR, Bansal N, et al. Nephrotic syndrome in pregnancy poses risks with both maternal and fetal complications[J]. Kidney Int, 2017, 91(6):1464-1472.
doi: S0085-2538(17)30003-0 pmid: 28233609 |
[9] |
Moroni G, Doria A, Giglio E, et al. Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study[J]. J Autoimmun, 2016, 74:194-200.
doi: 10.1016/j.jaut.2016.06.012 URL |
[10] |
Fredi M, Lazzaroni MG, Tani C, et al. Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies[J]. Autoimmun Rev, 2015, 14(8):686-691.
doi: 10.1016/j.autrev.2015.03.009 URL |
[11] |
Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcomes in patients with lupus: a cohort study[J]. Ann Intern Med, 2015, 163(3):153-163.
doi: 10.7326/M14-2235 pmid: 26098843 |
[12] |
Zhou H, Liu Y, Liu L, et al. Maternal pre-pregnancy risk factors for miscarriage from a prevention perspective: a cohort study in China[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 206:57-63.
doi: 10.1016/j.ejogrb.2016.07.514 URL |
[13] |
Nobles CJ, Mendola P, Mumford SL, et al. Pressure levels and reproductive outcomes in a prospective cohort of women attempting pregnancy[J]. Hypertension, 2018, 71(5):904-910.
doi: 10.1161/HYPERTENSIONAHA.117.10705 URL |
[14] | Wiles K, Chappell L, Clark K, et al. Clinical practice guideline on pregnancy and renal disease[J]. BMC Nephrol, 2019, 31, 20(1):401. |
[15] |
Harel Z, McArthur E, Hladunewich M, et al. Serum creatinine levels before, during, and after pregnancy[J]. JAMA, 2019, 321(2):205-207.
doi: 10.1001/jama.2018.17948 pmid: 30644975 |
[16] | Wiles K, Bramham K, Seed PT, et al. Serum creatinine in pregnancy: a systematic review[J]. Kidney Int Rep, 2018, 4(3):408-419. |
[17] |
Strevens H, Wide-Swensson D, Torffvit O, et al. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy[J]. Scand J Clin Lab Invest, 2002, 62(2):141-147.
doi: 10.1080/003655102753611771 URL |
[18] |
Bramham K, Makanjuola D, Hussein W, et al. Serum cystatin is not a marker of glomerular filtration rate in pregnancy[J]. Obstet Med, 2009, 2(3):121-122.
doi: 10.1258/om.2009.090019 URL |
[19] |
Piccoli GB, Cabiddu G, Attini R, et al. Risk of adverse pregnancy outcomes in women with CKD[J]. J Am Soc Nephrol, 2015, 26(8):2011-2022.
doi: 10.1681/ASN.2014050459 URL |
[20] |
Maynard SE, Thadhani R. Pregnancy and the kidney[J]. J Am Soc Nephrol, 2009, 20(1):14-22.
doi: 10.1681/ASN.2008050493 pmid: 19118150 |
[21] |
Waugh JJ, Bell SC, Kilby MD, et al. Optimal bedside urinalysis for the detection of proteinuria in hypertensive pregnancy: a study of diagnostic accuracy[J]. BJOG, 2005, 112(4):412-417.
doi: 10.1111/j.1471-0528.2004.00455.x URL |
[22] | Huang Q, Gao Y, Yu Y, et al. Urinary spot albumin:creatinine ratio for documenting proteinuria in women with preeclampsia[J]. Rev Obstet Gynecol, 2012, 5(1):9-15. |
[23] | Waugh J, Hooper R, Lamb E, et al. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis[J]. Health Technol Assess, 2017, 21(61):1-90. |
[24] |
Wiles K, Webster P, Seed PT, et al. The impact of chronic kidney disease stages 3-5 on pregnancy outcomes[J]. Nephrol Dial Transplant, 2020, 12:1-10.
doi: 10.1093/ndt/12.1.1 URL |
[25] | 陈洪, 周春华. 慢性肾脏病与妊娠[J]. 中华肾病研究电子杂志, 2018, 7(6):225-228. |
[26] |
Piccoli GB, Daidola G, Attini R, et al. Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review[J]. BJOG, 2013, 120(4):412-427.
doi: 10.1111/1471-0528.12111 URL |
[27] |
Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy[J]. N Engl J Med, 2015, 372 (5):407-417.
doi: 10.1056/NEJMoa1404595 URL |
[28] | 中华医学会妇产科学分会, 妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志, 2020, 55(4):227-238. |
[29] |
Brown MA, Magee LA, Kenny LC, et al. Hypertension in pregnancy(ISSHP). The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice[J]. Pregnancy Hypertens, 2018, 13:291-310.
doi: S2210-7789(18)30126-0 pmid: 29803330 |
[30] |
Bateman BT, Patorno E, Desai RJ, et al. Angiotensin-converting enzyme inhibitors and the risk of congenital malformations[J]. Obstet Gynecol, 2017, 129(1):174-184.
doi: 10.1097/AOG.0000000000001775 pmid: 27926639 |
[31] |
Bateman BT, Patorno E, Desai RJ, et al. Late pregnancy β blocker exposure and risks of neonatal hypoglycemia and bradycardia[J]. Pediatrics, 2016, 138:e20160731.
doi: 10.1542/peds.2016-0731 URL |
[32] |
Morgan JL, Kogutt BK, Meek C, et al. Pharmacokinetics of amlodipine besylate at delivery and during lactation[J]. Pregnancy Hypertens, 2018, 11:77-80.
doi: S2210-7789(17)30295-7 pmid: 29523279 |
[33] |
Bergman JEH, Lutke LR, Gans ROB, et al. Beta-blocker use in pregnancy and risk of specific congenital anomalies: a european case-malformed control study[J]. Drug Saf, 2018, 41(4):415-427.
doi: 10.1007/s40264-017-0627-x URL |
[34] |
Hviid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts[J]. CMAJ, 2011, 183(7):796-804.
doi: 10.1503/cmaj.101063 URL |
[35] |
Moroni G, Doria A, Giglio E, et al. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study[J]. J Autoimmun, 2016, 74:6-12.
doi: 10.1016/j.jaut.2016.07.010 URL |
[36] |
Flint J, Panchal S, Hurrell A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-part Ⅰ: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids[J]. Rheumatology (Oxford), 2016, 55(9):1693-1697.
doi: 10.1093/rheumatology/kev404 URL |
[37] |
Chakkera HA, Kudva Y, Kaplan B. Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus[J]. Clin Pharmacol Ther, 2017, 101(1):114-120.
doi: 10.1002/cpt.546 pmid: 27804122 |
[38] |
Kim H, Jeong JC, Yang J, et al. The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation[J]. Clin Transplant, 2015, 29(2):142-148.
doi: 10.1111/ctr.12494 URL |
[39] |
Flint J, Panchal S, Hurrell A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breast feeding-Part Ⅰ: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids[J]. Rheumatology(Oxford), 2016, 55(9):1693-1697.
doi: 10.1093/rheumatology/kev404 URL |
[40] |
Sanchez-Gonzalez LR, Castro-Melendez SE, Angeles-Torres AC, et al. Efficacy and safety of adjuvant recombinant human erythropoietin and ferrous sulfate as treatment for iron deficiency anemia during the third trimester of pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 205:32-36.
doi: 10.1016/j.ejogrb.2016.08.004 pmid: 27566219 |
[41] | Tariq N, Ayub R, Khan WU, et al. Parenteral iron therapy in the treatment of iron deficiency anemia during pregnancy: a randomized controlled trial[J]. J Coll Physicians Surg Pak, 2015, 25(3):193-197. |
[42] |
Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia[J]. N Engl J Med, 2017, 377(7):613-622.
doi: 10.1056/NEJMoa1704559 URL |
[43] |
Wiles KS, Nelson-Piercy C, Bramham K. Reproductive health and pregnancy in women with chronic kidney disea-se[J]. Nat Rev Nephrol, 2018, 14(3):165-184.
doi: 10.1038/nrneph.2017.187 pmid: 29355168 |
[44] |
van Dorp W, Mulder RL, Kremer LC, et al. Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup consortium[J]. J Clin Oncol 2016, 34(28): 3440-3450.
doi: 10.1200/JCO.2015.64.3288 URL |
[45] |
Donnez J, Dolmans MM. Fertility preservation in women[J]. N Engl J Med, 2017, 377(17):1657-1665.
doi: 10.1056/NEJMra1614676 URL |
[1] | 宋洛卿, 戴廷军. 原发性抗磷脂综合征合并烟雾综合征一例并文献复习[J]. 诊断学理论与实践, 2022, 21(04): 497-503. |
[2] | 郝旭, 王伟铭. 依靠肾活检确诊的以肾脏病变为主要表现的法布里病1例报告[J]. 诊断学理论与实践, 2022, 21(04): 527-529. |
[3] | 杜燕然, 焦景, 任芸芸, 周建桥. 超声影像组学技术在评估胎肺成熟度中的应用[J]. 诊断学理论与实践, 2022, 21(03): 326-330. |
[4] | 曹云云, 王冠杰, 曾敏, 王海飞, 牛建梅, 周雷平. 早孕期超声相关参数预测胚胎妊娠结局价值的分析[J]. 诊断学理论与实践, 2021, 20(05): 445-449. |
[5] | 范秋灵. 糖尿病肾病和非糖尿病慢性肾脏病患者应用钠-葡萄糖协同转运蛋白2抑制剂:预后评估及相关指南解读[J]. 诊断学理论与实践, 2021, 20(02): 130-137. |
[6] | 吴萍, 冯炜炜. 剖宫产瘢痕妊娠的临床管理及继续妊娠的探究[J]. 诊断学理论与实践, 2020, 19(1): 95-99. |
[7] | 左广民, 彭魁, 李勉, 徐敏, 毕宇芳, 宁光. 上海社区中老年人群脂肪肝指数与微量白蛋白尿的相关性研究[J]. 诊断学理论与实践, 2020, 19(06): 605-609. |
[8] | 余舒文, 方正滢, 谢静远. 基因检测在慢性肾脏病诊治中的应用及进展[J]. 诊断学理论与实践, 2020, 19(06): 613-617. |
[9] | 李贵森. 2019年《中国慢性肾脏病矿物质和骨异常诊治指南》解读[J]. 诊断学理论与实践, 2020, 19(03): 229-231. |
[10] | 林建华, 缪慧娴. 妊娠合并心脏病的分类诊断和妊娠风险评估[J]. 诊断学理论与实践, 2019, 18(06): 613-618. |
[11] | 姚小艳, 陈君. 上海地区孕妇维生素D水平调查及其与妊娠期糖尿病发生的相关性研究及其预测价值探索[J]. 诊断学理论与实践, 2019, 18(06): 634-639. |
[12] | 王媛媛, 范秋灵. 血清降钙素原在慢性肾脏病合并细菌感染患者中的临床价值[J]. 诊断学理论与实践, 2019, 18(03): 353-359. |
[13] | 黄亚, 徐利, 葛凤菊, 吴鋆龙, 陈亚宁, 祁秀娟. 激光辅助孵化完全去除透明带对冷冻单囊胚移植结局的影响[J]. 诊断学理论与实践, 2019, 18(03): 334-339. |
[14] | 叶岚, 张欢, 钱朝霞. 磁共振在异位妊娠中的影像表现及临床价值[J]. 诊断学理论与实践, 2017, 16(06): 650-655. |
[15] | 韩晓凤, 方怡, 朱坚轶, 黄洪晖, 陈芳源. 以反复流产为表现的阵发性睡眠性血红蛋白尿一例[J]. 诊断学理论与实践, 2017, 16(04): 430-431. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||